TrialJAMA network open2024

Zoledronate Sequential Therapy After Denosumab Discontinuation to Prevent Bone Mineral Density Reduction: A Randomized Clinical Trial.

Chia-Che Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.